CN Patent
CN109503573A — 2-取代苯胺基嘧啶衍生物及其用途
Assigned to Kunming Shengjianan Biological Technology Co Ltd · Expires 2019-03-22 · 7y expired
What this patent protects
本发明涉及具有式(I)的2‑取代苯胺基嘧啶衍生物及其盐,包括可药用盐,及其药物组合的制备方法和用途。此类化合物及其医药学上可接受的盐、溶剂合物、前药及药物组合适用于治疗疾病和病状,尤其是与细胞周期蛋白依赖性激酶CDK4/6的活性有关的疾病及病状,该等疾病及病状包含(但不限于)各种癌症和炎症。
USPTO Abstract
本发明涉及具有式(I)的2‑取代苯胺基嘧啶衍生物及其盐,包括可药用盐,及其药物组合的制备方法和用途。此类化合物及其医药学上可接受的盐、溶剂合物、前药及药物组合适用于治疗疾病和病状,尤其是与细胞周期蛋白依赖性激酶CDK4/6的活性有关的疾病及病状,该等疾病及病状包含(但不限于)各种癌症和炎症。
Drugs covered by this patent
- Verzenio (abemaciclib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.